Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer?

被引：56

作者：

Bergamini, Cristiana ^{[1
]}

Locati, Laura ^{[1
]}

Bossi, Paolo ^{[1
]}

Granata, Roberta ^{[1
]}

Alfieri, Salvatore ^{[1
]}

Resteghini, Carlo ^{[1
]}

Imbimbo, Martina ^{[1
]}

Fallai, Carlo ^{[2
]}

Orlandi, Ester ^{[2
]}

Tana, Silvia ^{[2
]}

Iacovelli, Nicola Alessandro ^{[2
]}

Guzzo, Marco ^{[3
]}

Ibba, Tullio ^{[3
]}

Colombo, Sarah ^{[3
]}

Bianchi, Roberto ^{[3
]}

Pizzi, Natalia ^{[3
]}

Fontanella, Walter ^{[3
]}

Licitra, Lisa ^{[1
]}

机构：

[1] Ist Nazl Tumori, Head & Neck Unit, Via Venezian 1, I-20100 Milan, Italy

[2] Ist Nazl Tumori, Radiotherapy Unit, Via Venezian 1, I-20100 Milan, Italy

[3] Ist Nazl Tumori, Otorinolaryngol Surg Unit, Via Venezian 1, I-20100 Milan, Italy

来源：

ORAL ONCOLOGY | 2016年 / 54卷

关键词：

Multidisciplinary team; Head and neck cancer; Guidelines; Second opinion; Treatment plan; PLUS CONCURRENT CISPLATIN; PHASE-II TRIAL; ALTERED FRACTIONATION; PATIENT-MANAGEMENT; CARCINOMAS; ONCOLOGY; CHEMORADIATION; RADIOTHERAPY; GUIDELINES; MEETINGS;

D O I：

10.1016/j.oraloncology.2016.01.001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Objectives: A multi-disciplinary team (MDT) is essential in the management of cancer. Head and neck cancer (HNC) is a rare, complex and heterogeneous group of malignancies for which different treatment options are available. However, the potential impact of MDT on the management of HNC has been only poorly evaluated to date. This study evaluates the impact of MDT on the management of HNC in a tertiary centre. Methods: We retrospectively analysed records of HNC patients referred to a MDT evaluation at the Istituto Nazionale Tumori of Milan, Italy, from May 2007 to January 2012. All cases were reviewed by a MDT consisting of a head and neck surgeon, a radiation oncologist, and a medical oncologist. Results: Data from 781 HNC patients were analysed. Approximately 70% of patients were referred to our Institution for a second opinion consultation. Following MDT evaluation, new staging examinations were requested in 49% of patients, and treatment plan was modified in 10%. Conclusions: A MDT approach in a tertiary referral hospital leads to staging refinement of disease or changes in treatment plan in about 60% of patients. (C) 2016 Elsevier Ltd. All rights reserved.

引用

页码：54 / 57

页数：4

共 31 条

[1] Acceleration of hyperfractionated chemoradiation regimen for advanced head and neck cancer [J].

Allen, Aaron M. ;

Elshaikh, Mohamed ;

Worden, Francis P. ;

Bradford, Carol R. ;

Teknos, Theodoros N. ;

Chepeha, Douglas B. ;

Tsien, Christina ;

Dawson, Laura A. ;

Urba, Susan ;

Wolf, Gregory T. ;

Normolle, Daniel ;

Eisbruch, Avraham .

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2007, 29 (02) :137-142

[2] Multidisciplinary management of locally advanced SCCHN: Optimizing treatment outcomes [J].

Ang, K. Kian .

ONCOLOGIST, 2008, 13 (08) :899-910

[3] Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: Radiation therapy oncology group phase II trial 99-14 [J].

Ang, KK ;

Harris, J ;

Garden, AS ;

Trotti, A ;

Jones, CU ;

Carrascosa, L ;

Cheng, JD ;

Spencer, SS ;

Forastiere, A ;

Weber, RS .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (13) :3008-3015

[4]

[Anonymous], 2004, GUID CANC SERV IMPR

[5] Altered fractionation and combined radio-chemotherapy approaches: pioneering new opportunities in head and neck oncology [J].

Bernier, J ;

Bentzen, SM .

EUROPEAN JOURNAL OF CANCER, 2003, 39 (05) :560-571

[6] Current State-of-the-Art for Concurrent Chemoradiation [J].

Bernier, Jacques .

SEMINARS IN RADIATION ONCOLOGY, 2009, 19 (01) :3-10

[7] Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival [J].

Bonner, James A. ;

Harari, Paul M. ;

Giralt, Jordi ;

Cohen, Roger B. ;

Jones, Christopher U. ;

Sur, Ranjan K. ;

Raben, David ;

Baselga, Jose ;

Spencer, Sharon A. ;

Zhu, Junming ;

Youssoufian, Hagop ;

Rowinsky, Eric K. ;

Ang, K. Kian .

LANCET ONCOLOGY, 2010, 11 (01) :21-28

[8] Hyperfractionated or accelerated radiotherapy in head and neck cancer:: a meta-analysis [J].

Bourhis, Jean ;

Overgaard, Jens ;

Audry, Helene ;

Ang, Kian K. ;

Saunders, Michele ;

Bernier, Jacques ;

Horiot, Jean-Claude ;

Le Maitre, Aurlie ;

Pajak, Thomas F. ;

Paulsen, Michael G. ;

O'Sullivan, Brian ;

Dobrowsky, Werner ;

Hliniak, Andrzej ;

Skladowski, Krzysztof ;

Hay, John H. ;

Pinto, Luiz H. J. ;

Fallai, Carlo ;

Fu, Karen K. ;

Sylvester, Richard ;

Pignon, Jean-Pierre .

LANCET, 2006, 368 (9538) :843-854

[9] Head and neck multidisciplinary team meetings: Effect on patient management [J].

Brunner, Markus ;

Gore, Sinclair M. ;

Read, Rebecca L. ;

Alexander, Ashlin ;

Mehta, Ankur ;

Elliot, Michael ;

Milross, Chris ;

Boyer, Michael ;

Clark, Jonathan R. .

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (07) :1046-1050

[10] Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].

Chan, A. T. C. ;

Gregoire, V. ;

Lefebvre, J. -L. ;

Licitra, L. ;

Hui, E. P. ;

Leung, S. F. ;

Felip, E. .

ANNALS OF ONCOLOGY, 2012, 23 :83-85

← 1 2 3 4 →